Market Overview The global human microbiome therapeutics market was valued at USD 508.70 million in 2022 and is expected to grow at a robust CAGR of 22.7% during the forecast period. Human microbiome therapeutics focuses on the development and application of targeted therapies that utilize microbiota to prevent, manage, or treat diseases. These therapies are driven by the growing...